Numbness in an arm, sudden vision problems, balance difficulties, or unexplained weakness. For many people, this is how multiple sclerosis (MS) begins. For years, the disease was primarily associated with disability, but modern medicine has significantly improved both diagnostic and treatment options. What is multiple sclerosis, what symptoms may appear in the early stages, and why is early diagnosis so important?

Multiple sclerosis (MS, sclerosis multiplex) is a chronic autoimmune disease of the central nervous system. In the course of the disease, the immune system mistakenly attacks the body’s own nervous system structures, leading to damage of the myelin sheath surrounding nerve fibers. This process disrupts the proper transmission of nerve impulses and results in a variety of neurological symptoms.
MS is one of the most common neurological disorders affecting young adults. The first symptoms most often appear between the ages of 20 and 40. The disease occurs approximately two to three times more frequently in women than in men. It is estimated that more than 2.8 million people worldwide are living with multiple sclerosis.
The exact cause of the disease has not yet been fully understood. Current evidence suggests that the development of MS results from a combination of genetic and environmental factors. Potential risk factors include infection with the Epstein–Barr virus (EBV), vitamin D deficiency, cigarette smoking, and certain genetic predispositions.
Multiple sclerosis is often referred to as the “disease with a thousand faces.” This is because its symptoms can vary greatly depending on the location of lesions within the nervous system. Two patients may experience the disease in completely different ways.
One of the most common early manifestations is optic neuritis. Patients may notice a sudden decrease in visual acuity, blurred vision, or eye pain that worsens with eye movement. For some individuals, this symptom is the first reason for seeking neurological evaluation.
Other common early symptoms include numbness and sensory disturbances in the limbs. Patients often describe these sensations as tingling, burning, electric shock-like feelings, or reduced sensation in a specific part of the body.
Some individuals experience balance problems, dizziness, muscle weakness, difficulty walking, or impaired coordination. Urinary symptoms, chronic fatigue, and problems with concentration may also occur.
A characteristic feature of the disease is the occurrence of relapses. A relapse refers to the appearance of new neurological symptoms or a significant worsening of existing symptoms lasting for at least 24 hours and not caused by infection or fever. In many patients, the early years of the disease are characterized by alternating periods of relapses and remissions.
The diagnosis of multiple sclerosis is based on clinical symptoms and additional diagnostic tests. Magnetic resonance imaging (MRI) plays a central role, allowing physicians to identify characteristic demyelinating lesions in the brain and spinal cord. In some cases, cerebrospinal fluid analysis and evoked potential studies may also be performed.
Until a few decades ago, a diagnosis of multiple sclerosis often caused significant anxiety due to concerns about long-term disability. Today, the situation is very different. Over the past two decades, there has been remarkable progress in the treatment of MS. Numerous disease-modifying therapies are now available that can reduce the frequency of relapses, decrease disease activity visible on MRI scans, and slow the progression of disability.
Current treatment options include beta interferons, glatiramer acetate, dimethyl fumarate, teriflunomide, fingolimod, ozanimod, cladribine, and modern monoclonal antibodies such as natalizumab, ocrelizumab, and ofatumumab. The choice of therapy depends on disease activity, the patient’s age, and individual clinical factors.
An increasing number of studies also highlight the importance of lifestyle factors. Regular physical activity, maintaining a healthy body weight, avoiding smoking, and ensuring adequate vitamin D supplementation may help support the overall health of people living with multiple sclerosis.
It is important to emphasize that modern multiple sclerosis is not the same disease it was considered to be several decades ago. Thanks to earlier diagnosis and more effective treatment options, many patients remain professionally active and maintain a good quality of life for many years.
In summary, multiple sclerosis is a chronic autoimmune disease of the central nervous system that can present with a wide variety of symptoms. Early diagnosis and prompt initiation of appropriate treatment play a crucial role in influencing the course of the disease and preserving quality of life.
Patient FAQ
Is multiple sclerosis a hereditary disease?
No. Genetic factors may increase the risk of developing multiple sclerosis, but the disease is not inherited in a simple or direct manner.
Can multiple sclerosis be detected through blood tests?
Currently, there is no single blood test that can diagnose multiple sclerosis. Laboratory tests are mainly used to rule out other conditions that may cause similar symptoms.
Does pregnancy worsen multiple sclerosis?
No. During pregnancy, the number of relapses often decreases. However, the risk of relapse may increase during the first few months after childbirth.
Is multiple sclerosis a fatal disease?
No. Thanks to modern treatment options, most patients live for many years, and the prognosis is significantly better than it was several decades ago.
Can multiple sclerosis be mistaken for other conditions?
Yes. Symptoms of MS may resemble those of several other disorders, including migraine, spinal disorders, Lyme disease, lupus, vitamin B12 deficiency, and certain vascular diseases.
References:
Multiple Sclerosis International Federation (MSIF). Atlas of MS 2023.
Thompson AJ et al. Diagnosis of multiple sclerosis: 2021 revisions of the McDonald criteria. Lancet Neurology.
Compston A, Coles A. Multiple sclerosis. The Lancet. 2008.
Dobson R, Giovannoni G. Multiple sclerosis – a review. European Journal of Neurology. 2019.
Filippi M et al. Multiple sclerosis. Nature Reviews Disease Primers. 2018.
National Multiple Sclerosis Society. Multiple Sclerosis Overview.
European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Guidelines.
American Academy of Neurology (AAN) Practice Guidelines for Multiple Sclerosis.